← Browse by Condition
Medical Condition
uremic toxemia
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for uremic toxemia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07123909
Recruiting
Studies on Adsorption International Learning Initiative Global
Enrollment
60 pts
Location
Russia
Sponsor
Botkin Hospital
NCT06561191
Recruiting
Functionality of Albumin in the Context of Hemodialysis
Enrollment
50 pts
Location
Germany
Sponsor
Universität Duisburg-Essen
NCT05659589
Recruiting
Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury
Enrollment
105 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology